Featured on: Market Wire
Publication date: May 29, 2009
Publication date: May 29, 2009
A statement by the medical research company Endogenous Stem Cells Activators, Inc. (ESAI) claims that the company's new medication, Kronos IV, which uses an active ingredient already in use to treat other conditions, may hold promise in spurring the brain's stem cells to repair the damage done by Alzheimer's Disease.
Read Full Article
Read Full Article
More Alzheimers Articles
MemoryXLTM, Vitamin-Nutraceutical Supplement, Improves Memory And Cognitive Performance In Both ANew Triggers Found For Alzheimer's
Brain Changes Observed In Unimpaired Older Humans Could Be Early Warning Of Alzheimer's
Future Alzheimer's Treatments May Be Effective Before The Onset Of Symptoms
Special Committee On Aging Discusses The Alzheimer
A 'heart Healthy' Diet And Ongoing, Moderate Physical Activity May Protect Against Cognitive Decline
Top Nutrients To Prevent Alzheimer's
Live Recordings Of Cell Communication
Critical Outcome Technologies Inc. Announces The Launch Of A Drug Discovery Program For Alzheimers
Indian Curry Could Prevent Alzheimer's Disease, Dementia
